The People Behind the Capital

Alex Euler has spent over two decades at the intersection of life sciences and venture capital. Prior to founding James Landing Capital, he held investment roles at leading healthcare-focused funds and served as an operator at multiple biopharma startups through clinical development and commercialization.

Alex holds advanced degrees in molecular biology and business, and brings a scientist's rigor to every investment decision. He is particularly drawn to platform technologies with the potential to address large, underserved disease areas.

Before his career in venture, Alex spent several years in academic research, which informs his conviction that the most durable companies in life sciences are built on genuinely differentiated science — not incremental improvements on existing approaches.